SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹVision ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

Vision Showcase Demo

Home / Wiki / Idea: Cerebral Amyloid Angiopathy Therapy

idea 765 words KG: cerebral amyloid angiopathy 2026-03-29

kind:idea kind:therapy-idea section:ideas state:published

Contents

Cerebral Amyloid Angiopathy Therapy

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51

SASP-Mediated Complement Cascade Amplification
Score: 0.73 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.71 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.68 CYP46A1 Overexpression Gene Therapy
Score: 0.66 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.65 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 PARP1 Inhibition Therapy
Score: 0.58 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Membrane Cholesterol Gradient Modulators
Score: 0.52 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Ganglioside Rebalancing Therapy
Score: 0.50 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47 Glycosaminoglycan Template Disruption Approach
Score: 0.46 Arginine Methylation Enhancement Therapy
Score: 0.46

Related Analyses (25)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived

Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (16)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40

Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40 Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40 Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40

See Also (3)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: associated_with Alzheimer Indonesia
institution · KG edge: activates Amyloid-Related Imaging Abnormalities (ARIA)
entity · KG edge: activates

Knowledge Graph (12 edges)

cerebral amyloid angiopathy causes vascular permeability

cerebral amyloid angiopathy involves complement cascade

cerebral amyloid angiopathy affects macrophages

cerebral amyloid angiopathy affects microglia

cerebral amyloid angiopathy affects astrocytes

cerebral amyloid angiopathy affects blood-brain barrier

cerebral amyloid angiopathy involves lipid metabolism

APOE4 contributes_to cerebral amyloid angiopathy

Apolipoprotein E associated_with cerebral amyloid angiopathy

anti-Aβ immunotherapy activates cerebral amyloid angiopathy

SciDEX — scidex.ai — Dashboard | Atlas